Sermo docs prefer Epocrates app: poll

Share this article:
Doctors responding to an MM&M survey hosted by Sermo—a social network for practicing physicians—said they use the Epocrates mobile app more often for work purposes than any other app.
The Epocrates app was a clear winner, with 53 of 73 physicians (73%) naming the drug reference app as one of the most used on a daily basis. WebMD's Medscape app came in second place, with 27 docs (37%) listing Medscape as a most used app on the day-to-day, practice level.
Others apps mentioned included MedCalc, a clinical calculator (11 docs); Stat ICD-9 (11 docs), a diagnosis coding app; and Fingertip Formulary, a health plan and drug tier status reference app. Eleven docs cited the Sermo app as a most-used application. One doc listed Merck's MerckMedicus as a most-used app, and six said they don't currently use any apps at work, but plan to in the near future, according to the poll results.
Basic versions of the most used apps cited by Sermo docs are available free of charge, and indeed, 66% of survey respondents said they prefer free, ad-supported apps over paid apps. Thirty-four percent said they are willing to pay for an app without advertisements.
Eighty percent of the docs surveyed said they do not use apps developed by pharma companies, according to the survey. Apple's iPhone was the favored mobile device for doctors (40%), with Google's Android in second place (21%), followed by Blackberry at 7%. Six percent said they use both the iPhone and iPad.
In comments on the survey, physicians discussed new tablet announcements at the Consumer Electronics Association's International CES tradeshow, as well as the pros and cons of iPhone and Android operating systems. A physician commenting on the larger screen size of upcoming Toshiba and Motorola tablets said a screen size larger than the iPad “will be necessary” for tablets to be increasingly useful “in a clinical setting.”  
Sermo hosted the MM&M survey on its site beginning January 6. Results are culled from responses posted between January 6 and 10.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.